Reversibility of the interaction of strophanthidin bromoacetate with the cardiotonic steroid binding site of sodium- and potassium-dependent adenosine triphosphatase.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000201:enzymology*; D002297:Cardanolides / Q000494:pharmacology; D004492:Edetic Acid; D006027:Glycosides / Q000378:metabolism; D066298:In Vitro Techniques; D008274:Magnesium; D010042:Ouabain / Q000494:pharmacology; D010761:Phosphorus Radioisotopes; D011188:Potassium; D051381:Rats; D012964:Sodium; D013997:Time Factors; D014316:Tritium
D002297:Cardanolides; D006027:Glycosides; D010761:Phosphorus Radioisotopes; D014316:Tritium; D010042:Ouabain; D004492:Edetic Acid; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011188:Potassium